Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
255 participants
OBSERVATIONAL
2021-06-06
2025-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nexplanon Application Post-Abortion (NAPA)
NCT02037919
Implants on Mobile Health Unit
NCT03347539
Quick Start of Highly Effective Contraception
NCT02076217
Improving Adolescent Adherence to Hormonal Contraception
NCT00584038
Nexplanon Use in Women Primarily Choosing a Combined Oral Contraceptive
NCT04423055
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The purpose of this study is to compare Nexplanon decision-making, uptake, satisfaction and contraceptive outcomes (continuation, switching, discontinuation) over a 12-month period among adolescents ages 15-18 to adolescents ages 19-24, living in Utah. Data from this study will provide valuable information for clinical and public health offerings, counseling and support for Nexplanon use across stages of adolescence.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adolescent females, aged 15-18
Adolescents females aged 15-18, who selected a contraceptive implant to prevent pregnancy.
Contraceptive use (continuation/switching/discontinuation)
Assessing contraceptive continuation/switching/discontinuation over 12-months
Adolescent females, aged 19-24
Adolescents females aged 19-24, who selected a contraceptive implant to prevent pregnancy.
Contraceptive use (continuation/switching/discontinuation)
Assessing contraceptive continuation/switching/discontinuation over 12-months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Contraceptive use (continuation/switching/discontinuation)
Assessing contraceptive continuation/switching/discontinuation over 12-months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Not currently pregnant;
* Planning to avoid pregnancy for the next 12 months;
* Selecting the contraceptive implant as their contraceptive method of choice;
* Willing to be contacted via email survey 4 times over 12-months
Exclusion Criteria
15 Years
24 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Utah
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rebecca Simmons
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Utah
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Berlan ED, Richards MJ, Vieira CS, Creinin MD, Kaunitz AM, Fraser IS, Edelman A, Mansour D. Best Practices for Counseling Adolescents about the Etonogestrel Implant. J Pediatr Adolesc Gynecol. 2020 Oct;33(5):448-454. doi: 10.1016/j.jpag.2020.06.022. Epub 2020 Jul 2.
Sawyer SM, Azzopardi PS, Wickremarathne D, Patton GC. The age of adolescence. Lancet Child Adolesc Health. 2018 Mar;2(3):223-228. doi: 10.1016/S2352-4642(18)30022-1. Epub 2018 Jan 30.
Downey MM, Arteaga S, Villasenor E, Gomez AM. More Than a Destination: Contraceptive Decision Making as a Journey. Womens Health Issues. 2017 Sep-Oct;27(5):539-545. doi: 10.1016/j.whi.2017.03.004. Epub 2017 Apr 12.
Diedrich JT, Klein DA, Peipert JF. Long-acting reversible contraception in adolescents: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017 Apr;216(4):364.e1-364.e12. doi: 10.1016/j.ajog.2016.12.024. Epub 2016 Dec 28.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB_00142231
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.